Nexgel Inc (NXGL) - Total Assets
Based on the latest financial reports, Nexgel Inc (NXGL) holds total assets worth $11.60 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nexgel Inc - Total Assets Trend (2016–2025)
This chart illustrates how Nexgel Inc's total assets have evolved over time, based on quarterly financial data. Also see NXGL stock market capitalisation for the company's overall valuation and market capitalisation.
Nexgel Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Nexgel Inc's total assets of $11.60 Million consist of 41.5% current assets and 58.5% non-current assets. Review debt load of Nexgel Inc to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.0% |
| Accounts Receivable | $673.00K | 6.4% |
| Inventory | $2.11 Million | 20.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $681.00K | 6.5% |
| Goodwill | $1.13 Million | 10.8% |
Asset Composition Trend (2016–2025)
This chart illustrates how Nexgel Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Nexgel Inc stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nexgel Inc's current assets represent 41.5% of total assets in 2025, an increase from 20.4% in 2016.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2025, up from 0.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 16.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 20.2% of total assets.
Nexgel Inc Competitors by Total Assets
Key competitors of Nexgel Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
Jiangxi Sanxin Medtec Co Ltd
SHE:300453
|
China | CN¥2.44 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
|
Dentium
KO:145720
|
Korea | ₩932.79 Billion |
|
Interojo Inc
KQ:119610
|
Korea | ₩252.22 Billion |
Nexgel Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.70 | 1.88 | 0.51 |
| Quick Ratio | 1.02 | 1.15 | 0.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.32 Million | $2.22 Million | $-861.00K |
Nexgel Inc - Advanced Valuation Insights
This section examines the relationship between Nexgel Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.86 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | -4.8% |
| Total Assets | $10.46 Million |
| Market Capitalization | $2.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nexgel Inc's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Nexgel Inc's assets decreased by 4.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Nexgel Inc (2016–2025)
The table below shows the annual total assets of Nexgel Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $10.46 Million | -4.75% |
| 2024-12-31 | $10.98 Million | +10.33% |
| 2023-12-31 | $9.96 Million | -3.88% |
| 2022-12-31 | $10.36 Million | -39.02% |
| 2021-12-31 | $16.98 Million | +652.46% |
| 2020-12-31 | $2.26 Million | +19.42% |
| 2019-12-31 | $1.89 Million | +155.75% |
| 2018-12-31 | $739.00K | -17.34% |
| 2017-12-31 | $894.00K | -29.10% |
| 2016-12-31 | $1.26 Million | -- |
About Nexgel Inc
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It a… Read more